A detailed history of Allworth Financial LP transactions in Bio Rad Laboratories, Inc. stock. As of the latest transaction made, Allworth Financial LP holds 39 shares of BIO stock, worth $13,353. This represents 0.0% of its overall portfolio holdings.

Number of Shares
39
Previous 45 13.33%
Holding current value
$13,353
Previous $12,000 8.33%
% of portfolio
0.0%
Previous 0.0%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 23, 2024

SELL
$263.97 - $344.64 $1,583 - $2,067
-6 Reduced 13.33%
39 $13,000
Q2 2024

Jul 23, 2024

SELL
$268.26 - $339.48 $3,219 - $4,073
-12 Reduced 21.05%
45 $12,000
Q1 2024

Apr 25, 2024

BUY
$304.11 - $351.99 $3,345 - $3,871
11 Added 23.91%
57 $19,000
Q4 2023

Jan 24, 2024

SELL
$269.37 - $365.04 $9,427 - $12,776
-35 Reduced 43.21%
46 $14,000
Q3 2023

Oct 31, 2023

BUY
$350.25 - $422.63 $3,502 - $4,226
10 Added 14.08%
81 $29,000
Q2 2023

Jul 18, 2023

SELL
$359.49 - $486.4 $7,908 - $10,700
-22 Reduced 23.66%
71 $26,000
Q1 2023

Apr 18, 2023

BUY
$418.69 - $503.0 $15,491 - $18,611
37 Added 66.07%
93 $44,000
Q4 2022

Jan 13, 2023

SELL
$351.71 - $456.01 $29,191 - $37,848
-83 Reduced 59.71%
56 $0
Q3 2022

Oct 18, 2022

BUY
$412.59 - $563.26 $46,210 - $63,085
112 Added 414.81%
139 $58,000
Q2 2022

Jul 13, 2022

BUY
$463.67 - $597.16 $11,591 - $14,929
25 Added 1250.0%
27 $13,000
Q1 2022

Apr 22, 2022

SELL
$524.57 - $735.42 $11,540 - $16,179
-22 Reduced 91.67%
2 $1,000
Q4 2021

Jan 21, 2022

BUY
$708.84 - $794.68 $17,012 - $19,072
24 New
24 $18,000
Q2 2021

Aug 02, 2021

SELL
$576.64 - $649.04 $40,364 - $45,432
-70 Closed
0 $0
Q4 2019

Jan 16, 2020

BUY
$319.73 - $374.2 $22,381 - $26,194
70 New
70 $26,000

Others Institutions Holding BIO

About BIO-RAD LABORATORIES, INC.


  • Ticker BIO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 24,633,900
  • Market Cap $8.43B
  • Description
  • Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...
More about BIO
Track This Portfolio

Track Allworth Financial LP Portfolio

Follow Allworth Financial LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Allworth Financial LP, based on Form 13F filings with the SEC.

News

Stay updated on Allworth Financial LP with notifications on news.